alexa Prolotherapy: The First Choice In Regenerative Medicine
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Joint Conference:3rd International Conference & Exhibition on TISSUE PRESERVATION AND BIOBANKING & 6th International Conference onTISSUE ENGINEERING AND REGENERATIVE MEDICINE
August 23-24, 2017 San Francisco, USA

Charles F Mahl
GenLife Regenerative Medicine, USA
Keynote: J Tissue Sci Eng
DOI: 10.4172/2157-7552-C1-032
Abstract
Prolotherapy has been around for almost 80 years, yet is not well known in most musculoskeletal circles. Most orthopedic surgeons and neurosurgeons either have not ever heard of prolotherapy or think it does not work based on never having studied it in residency training programs, their personal bias or their general lack of knowledge about it. The author will explain his discovery of prolotherapy after some 30 years of suffering from pain and his experience and will introduce this fine medical art to the participants. Prolotherapy was the first procedure invented in Regenerative Medicine, followed by PRPPlatelet Rich Plasma injections and then Stem Cell Injections from the bone marrow and/or adipose tissue. Prolotherapy is a simple technique, much less invasive and less harmful as compared to steroid injections and high risk musculoskeletal surgery and often times, when performed by a skilled and experienced prolotherapist can alleviate the chronic pain one is suffering from. The author will explain the physiology of ligaments and tendons in response to prolotherapy and differentiate between 1st line, 2nd line and 3rd line regenerative medicine therapies. Prolotherapy is the first line of defense when it comes to regenerative medicine and should be recommended to patients prior to cortisone injections or invasive surgery. Elite athletes are already aware of its potential and utilize it when injured and or reinjured to heal their painful joints. It is time for prolotherapy to become main stream and no longer be considered alternative medicine. Author will describe the indications for prolotherapy, the techniques utilized and indications for this therapy. Prolotherapy is an extremely successful therapy in experienced hands and offers powerful pain relief and healing, especially to those who cannot afford PRP or Stem Cells and is therefore, a therapy that be part of all physicians training in third world countries and the like where large percentages of the population cannot afford or have no access to PRP or stem cells. For an indigent population, prolotherapy offers a very good treatment for healing and relief of musculoskeletal pain. Any physician doing stem cell therapy (musculoskeletal) should be well trained in prolotherapy prior to using the advanced therapies of performing platelet rich plasma injections (PRP) and bone marrow aspirates for stem cells and liposuctions for adipose derived stem cells. These procedures are very expensive as compared to prolotherapy. You need to have a major knowledge of injection techniques and know your anatomy-bones, ligaments, tendons and muscles in order to put the cells where they need to be. You need to be able to do these procedures via head, heart and hand (palpation) and via ultrasonic guidance and C-arm Fluoroscopy for more precision. Before rushing into doing stem cell therapies, prolotherapy should be tried because it is a much simpler and less invasive technique. Prolotherapy is currently being performed as a precursor to having PRP and stem cell therapy by competent regenerative medicine doctors. A discussion of what is prolotherapy and its uses and what it does is germane to this talk. It is important for physicians to know that often a simple treatment can be performed to accomplish the same result as long as one is experienced and knowledgeable as a prolotherapist.
Biography

Charles F Mahl is a graduate of Case Western Reserve University in Cleveland, Ohio. He has received his MD degree from the Rosalind Franklin School of Medicine in Chicago, Illinois. He did his Residency and Chief Residency in New York at Interfaith Hospital and Vitreo Retinal Fellowship at the University of Oregon. He has completed a Fellowship program in Anti-Aging and Regenerative Medicine by the American Academy of Anti-Aging Medicine, the Living Younger Preventive Aging Program and is certified in Age Management Medicine by The Cenegenics Education and Research Foundation. He is Regenestem trained in both PRP and adipose/bone marrow derived stem cells. He is Board Certified in Integrative Medicine (BCIM) and is a Certified Sports Trainer (CST) and Certified Sports Nutritionist (CSN). He is also a Member of the Advisory Board of Global Stem Cells and Regenestem.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version